Sign in
CompletedNo phase

SMART Concussion Trial: Symptom Management vs Alternative Randomized Treatment of Concussion Trial

Key facts

Who runs it
University of Calgary
Where
Canada1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
62 people enrolled
Started
10 Apr 2023
Ended
31 Jan 2025
Type of study
Interventional, 3 groups
Treatments tested
  • Symptom-specific Headache Treatment
  • Symptom-specific Dizziness &/or Neck Pain Treatment
  • Multimodal Concussion Treatment
Record updated
11 June 2026

Who can take part

Age
13 years to 19 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 25 criteriaShow less

Who can take part

  • 13 - 19 years of age at the start of treatment
  • Diagnosed by the study physician with a concussion as per the 5th International Consensus Statement on Concussion in Sport1
  • Glasgow Coma Scale 13-15 if recorded
  • Loss of consciousness < 30 minutes if present
  • Post-traumatic amnesia < 24 hours if present
  • Diagnosis within 2 weeks of injury
  • Moderate-severe symptoms of dizziness, neck pain, headaches, or sleep disturbance at > one week and < three weeks post injury reported on the PCSS (3-6 on 0-6 Likert scale for at least one of three symptoms)
  • Patients can have a history of migraine or a family history of migraine

Who cannot take part

  • Medical history of neurological conditions: seizures (febrile SZ will be allowed), stroke, previous moderate/severe TBI, CNS cancers, SCI
  • Steroid injection to the greater or lesser occipital nerve infiltration in past 3 months
  • Previously enrolled in the trial
  • Psychotic disorder
  • History of surgery in the occipital region
  • Uncontrolled rheumatologic, inflammatory, or neurologic disorders (eg MS); Fibromyalgia/chronic fatigue syndrome; coagulopathy; immunosuppression
  • Active cancer
  • Herpes zoster infection in last 6 months
  • Inability to communicate orally and/or in writing in English language
  • Significant developmental delay or intellectual disability
  • No access to smartphone or computer
  • Red flags or other clinical indication suggesting that further medical investigation is warranted (e.g., neurological scan - reflexes, dermatomes, myotomes, long tract signs, CN II-XII, Cerebellar Scan
  • Unresolved Benign Paroxysmal Positional Vertigo (BPPV) (Dix-Hallpike and Roll Test)
  • Inability to participate in physical activity for a reason other than concussion
  • Orthopedic or other injury precluding ability to participate
  • Inability to provide informed consent
  • Pregnancy

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Given the rising rates of concussion in youth ages 10-19 and the significant proportion of young people who remain symptomatic for months following concussion, research evaluating the efficacy of multifaceted treatment options following concussion is imperative. Studies examining the efficacy of treatment strategies following concussion in children and adults are surprisingly limited, and most focus on one treatment approach, have small sample sizes, are not randomized controlled trials, and focus on individuals with prolonged recovery (months). There is a need for a multifaceted treatment trial to examine the early implementation of treatment approaches that may reduce prolonged recovery while considering the heterogeneous presentation of symptoms and patient preferences in the sub-acute stage following concussion. Randomized controlled trials that consider a multifaceted transdisciplinary approach to treatment in the early period following concussion are needed to raise the bar regarding evidence-informed management following concussion

The 3 groups in the trial

  • Headache TreatmentTreatment being tested

    Participants in the headache arm will be randomized to receive a peripheral, greater occipital nerve block with 0.5% Bupivacaine or the multimodal treatment protocol. Participants will complete a daily headache diary over the 6-week treatment period, following a link on their mobile device. Patients receiving a nerve block will have weekly over-the-phone or virtual check-ins by the study team to evaluate for any side effects, pain, as needed medications, and study compliance. These patients will be given supplemental HA education as needed. Participants receiving the block will be offered a second block at 6 weeks if they meet the following criteria: a. no side effects with the first block, b. participant received relief from the first block and prefers a second, and c. headache is still occurring at least once per week. Participants randomized to the multimodal treatment portion, will have up to 6 weeks of scheduled multimodal treatment sessions.

    Treatment: Symptom-specific Headache Treatment and Multimodal Concussion Treatment

  • Dizziness and/or Neck Pain TreatmentTreatment being tested

    Participants will be randomized to receive cervicovestibular physiotherapy (CV PT) or the multimodal treatment program. The CV PT group will participate in a combination of cervical spine and vestibular rehabilitation as per a standardized treatment algorithm based on individual assessment findings for six weeks. This form of therapy combines treatment techniques for both the cervical spine and vestibular system that are commonly used in physiotherapy practice. Cervical spine treatments may include neuromotor retraining, sensorimotor retraining, manual therapy, soft tissue techniques, and range of motion exercises. Vestibular rehabilitation may include gaze stabilization, habituation, standing balance, and dynamic balance.

    Treatment: Symptom-specific Dizziness &/or Neck Pain Treatment and Multimodal Concussion Treatment

  • Multimodal TreatmentTreatment being tested

    The multimodal treatment consists of 6 treatment sessions that will combine basic physiotherapy exercises to address dizziness and balance problems, training in deep breathing, progressive muscle relaxation, visualization to address headache, sleep hygiene education to address insomnia, and cognitive-behavioral intervention and gratitude exercises to promote coping and resilience. The treatment is designed to be implemented by a variety of clinical health care professionals.

    Treatment: Multimodal Concussion Treatment

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Symptom Management vs Alternative Randomized Treatment of Concussion Trial
Record updated
11 June 2026